UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HPV vaccines – A review of the first decade

Gynecologic oncology, 2017-07, Vol.146 (1), p.196-204

2017

Volltextzugriff (PDF)

Primary Strategies for HPV Infection and Cervical Cancer Prevention

Clinical obstetrics and gynecology, 2014-06, Vol.57 (2), p.256-278

2014

Volltextzugriff (PDF)

Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents

Reproductive biology and endocrinology, 2019-01, Vol.17 (1), p.16-16, Article 16

2019

Volltextzugriff (PDF)

B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity

The Journal of immunology (1950), 2015-06, Vol.194 (11), p.5305-5311

2015

Volltextzugriff (PDF)

Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer

Gynecologic oncology, 2016-12, Vol.143 (3), p.504-510

2016

Volltextzugriff (PDF)

Will increasing dosing intervals decrease the loss of anti-HPV seropositivity over time?

Vaccine, 2018-08, Vol.36 (33), p.4966-4966

2018

Volltextzugriff (PDF)

Corrigendum to “HPV vaccines—A review of the first decade” [Gynecol. Oncol. 146 (2017) 196–204]

Gynecologic oncology, 2017-11, Vol.147 (2), p.489-489

2017

Volltextzugriff (PDF)

Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer

Cancer gene therapy, 2022-03, Vol.29 (3-4), p.369-382

2022

Volltextzugriff (PDF)

Hypothesis generating data – HPV vaccines – A decade in review

Gynecologic oncology reports, 2017-11, Vol.22 (C), p.115-116

2017

Volltextzugriff (PDF)

Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer

Cancer research (Chicago, Ill.), 2007-05, Vol.67 (10), p.5003-5008

2007

Volltextzugriff (PDF)

Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer: A Phase II Study

International journal of gynecological cancer, 2014-11, Vol.24 (9), p.1583-1589

2014

Volltextzugriff (PDF)

EP014/#408 Evaluation of NAPI2B expression in a well annotated longitudinal tissue series of ovarian serous carcinomas

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A54-A54

2022

Volltextzugriff (PDF)

Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome

Human pathology, 2017-12, Vol.70, p.121-128

2017

Volltextzugriff (PDF)

Treatment patterns of advanced or recurrent endometrial cancer following platinum-based therapy in the U.S. real-world setting

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.274-274

2020

Volltextzugriff (PDF)

Treatment patterns of advanced or recurrent endometrial cancer following platinum-based therapy in the US real-world setting

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e18036-e18036

2020

Volltextzugriff (PDF)

Breaking from the paradigm of antibody-drug conjugates: Evaluation of clinical pharmacokinetics and safety of bicycle toxin conjugates (BTCs)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3088-3088

2024

Volltextzugriff (PDF)

EP017/#425 Comparison of NAPI2B expression from paired tissue samples in a clinical study of upifitamab rilsodotin (UPRI; XMT-1536) supports a strategy of testing in archive material

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A55-A56

2022

Volltextzugriff (PDF)

Vulvar Epithelioid Sarcoma in Pregnancy

Gynecologic oncology, 2002-04, Vol.85 (1), p.218-222

2002

Volltextzugriff (PDF)

TP036/#426 Uplift (ENGOT-OV67/GOG-3048) a pivotal cohort of the XMT-1536–1 trial of upifitamab rilsodotin (XMT-1536; UPRI), a NAPI2B-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A241-A241

2022

Volltextzugriff (PDF)

Human Immunodeficiency Virus–Specific and CD3-Redirected Cytotoxic T Lymphocyte Activity in the Human Female Reproductive Tract: Lack of Correlation between Mucosa and Peripheral Blood

The Journal of infectious diseases, 2001-03, Vol.183 (6), p.977-983

2001

Volltextzugriff (PDF)

High prevalence of allergy in patients undergoing in vitro fertilization and embryo transfer

Journal of assisted reproduction and genetics, 2020-02, Vol.37 (2), p.311-320

2020

Volltextzugriff (PDF)

2022-RA-459-ESGO UPLIFT (ENGOT-ov67/GOG-3048) a registrational trial of Upifitamab Rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer

International journal of gynecological cancer, 2022-10, Vol.32 (Suppl 2), p.A237-A237

2022

Volltextzugriff (PDF)

Gliomatosis peritonei and teratomatous implant with carcinomatous transformation presenting 54 years following oophorectomy for dermoid cyst

Gynecologic oncology, 2004, Vol.92 (1), p.353-356

2004

Volltextzugriff (PDF)

B7H6-specific chimeric antigen receptors lead to tumor elimination and host anti-tumor immunity

Gene therapy, 2015-04, Vol.22 (8), p.675-684

2015

Volltextzugriff (PDF)

B7H6-specific bispecific T cell engagers (BiTEs) lead to tumor elimination and host anti-tumor immunity1,2

The Journal of immunology (1950), 2015-04, Vol.194 (11), p.5305-5311

2015

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HPV vaccines – A review of the first decade

Primary Strategies for HPV Infection and Cervical Cancer Prevention

Egg freezing for fertility preservation and family planning: a nationwide survey of US Obstetrics and Gynecology residents

B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity

Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer

Will increasing dosing intervals decrease the loss of anti-HPV seropositivity over time?

Corrigendum to “HPV vaccines—A review of the first decade” [Gynecol. Oncol. 146 (2017) 196–204]

Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer

Hypothesis generating data – HPV vaccines – A decade in review

Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer

Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer: A Phase II Study

EP014/#408 Evaluation of NAPI2B expression in a well annotated longitudinal tissue series of ovarian serous carcinomas

Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome

Treatment patterns of advanced or recurrent endometrial cancer following platinum-based therapy in the U.S. real-world setting

Treatment patterns of advanced or recurrent endometrial cancer following platinum-based therapy in the US real-world setting

Breaking from the paradigm of antibody-drug conjugates: Evaluation of clinical pharmacokinetics and safety of bicycle toxin conjugates (BTCs)

EP017/#425 Comparison of NAPI2B expression from paired tissue samples in a clinical study of upifitamab rilsodotin (UPRI; XMT-1536) supports a strategy of testing in archive material

Vulvar Epithelioid Sarcoma in Pregnancy

TP036/#426 Uplift (ENGOT-OV67/GOG-3048) a pivotal cohort of the XMT-1536–1 trial of upifitamab rilsodotin (XMT-1536; UPRI), a NAPI2B-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer

Human Immunodeficiency Virus–Specific and CD3-Redirected Cytotoxic T Lymphocyte Activity in the Human Female Reproductive Tract: Lack of Correlation between Mucosa and Peripheral Blood

High prevalence of allergy in patients undergoing in vitro fertilization and embryo transfer

2022-RA-459-ESGO UPLIFT (ENGOT-ov67/GOG-3048) a registrational trial of Upifitamab Rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer

Gliomatosis peritonei and teratomatous implant with carcinomatous transformation presenting 54 years following oophorectomy for dermoid cyst

B7H6-specific chimeric antigen receptors lead to tumor elimination and host anti-tumor immunity

B7H6-specific bispecific T cell engagers (BiTEs) lead to tumor elimination and host anti-tumor immunity1,2

Suchergebnisse filtern